AAPS

AAPS 2021

American Association of Pharmaceutical Scientists

DATE

October 17th – 20th, 2021

LOCATION

Pennsylvania Convention Center | Philadelphia, PA USA

ABOUT AAPS

Founded in 1986, the American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 7,000 individual members and over 10,000 actively participating stakeholders employed in academia, industry, government, and other pharmaceutical science related research institutes worldwide.

EVENT WEBSITE

For more information, or to register please visit: AAPS

BOOTH INFO

We will be exhibiting both in-person and virtually at AAPS 2021. Our booth is #433! Schedule time with our subject matter experts here.

WuXi AppTec will be hosting a presentation as well as a post-show webinar. We will also be presenting two posters.

Presenter: Dr. Jing Shi

Title: The Unique Bioanalytical Needs of New Modalities

Overview: This presentation focuses on the bioanalytical challenges and considerations for RNA-based drugs, bispecific antibodies and multi-domain protein therapeutics, prodrugs, gene and cell therapies, and fusion proteins. Methods ranging from the conventional ligand binding assays and liquid chromatography-mass spectrometry assays to quantitative polymerase chain reaction or flow cytometry often used for oligonucleotides and cell and gene therapies are discussed.

POSTER INFO

Author: Liying Jiang

Title: Quantification of Various Types of Oligonucleotides in Plasma and Tissue Matrix by LC-MS/MS or LC-FLD

Author: Jing Huang

Title: Determination of Modified Thymidine Phosphorylase Concentration and its Activity in Mouse Serum by LC-MS/MS

PRESENTATION | POST SHOW WEBINAR

Presenter: Dr. Jing Shi

Title: The Unique Bioanalytical Needs of New Modalities

Overview: This presentation focuses on the bioanalytical challenges and considerations for RNA-based drugs, bispecific antibodies and multi-domain protein therapeutics, prodrugs, gene and cell therapies, and fusion proteins. Methods ranging from the conventional ligand binding assays and liquid chromatography-mass spectrometry assays to quantitative polymerase chain reaction or flow cytometry often used for oligonucleotides and cell and gene therapies are discussed.